Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
IL-25 prevents T cell-mediated neurotoxicity by decreasing LFA-1 expression.
Role of T Follicular Helper cells in Multiple Sclerosis.
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation.
Immune suppression of JC virus gene expression is mediated by SRSF1.
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
Levels and actions of neuroactive steroids in the nervous system under physiological and pathological conditions: Sex-specific features.
A case of simultaneous neuromyelitis optica spectrum disorder and subacute combined degeneration.
Accurate white matter lesion segmentation by k nearest neighbor classification with tissue type priors (kNN-TTPs).
The role of N-Glycan modification of TNFR1 in inflammatory microglia activation.
Selective upregulation of scavenger receptors in and around demyelinating areas in multiple sclerosis.
Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.
Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis.
Astrocytes Surviving Severe Stress Can Still Protect Neighboring Neurons from Proteotoxic Injury.
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis.
[Multiple sclerosis: oral drugs].
Scale Adjustments to Facilitate Two-Dimensional Measurements in OCT Images.
Pharmaceutical approval update.
Effects of isoxazolo-pyridinone 7e, a potent activator of the nurr1 signaling pathway, on experimental autoimmune encephalomyelitis in mice.
Vitamin D levels in multiple sclerosis patients: Association with TGF-β2, TGF-βRI, and TGF-βRII expression.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
Natalizumab treatment for multiple sclerosis: Middle East and North Africa regional recommendations for patient selection and monitoring.
Predictive value of 1 month retinal nerve fiber layer thinning for deficits at 6 months after acute optic neuritis.
[Research status on the epidemiological characteristics of optic neuritis].
Pages
« first
‹ previous
…
515
516
517
518
519
520
521
522
523
…
next ›
last »